Summary
The disposition of salicylic acid and salicyluric acid was studied in 57 Ethiopian children of varying nutritional status after oral administration of sodium salicylate in single doses of either 12.5 or 25 mg/kg. There was no apparent influence of nutritional status on oral salicylate disposition when related to total plasma concentrations. Unbound concentrations were predicted from total plasma concentrations on the basis of a single time point determination of protein binding in each individual, according to a Scatchard model. Areas under the unbound plasma concentration-time curve were larger and the fractional excretion of salicyluric acid was lower in children with kwashiorkor compared with control individuals. This was interpreted as lower hepatocellular metabolic activity in patients with kwashiorkor. Children with marasmus retained an unimpaired capacity for salicylate metabolism. The influence of saturable distribution and elimination are discussed.
Similar content being viewed by others
References
Alleyne GAO. Cardiac function in severely malnourished Jamaican children. Clinical Science 30: 553–562, 1966
Alleyne GAO. The effect of severe protein calorie malnutrition on the renal function of Jamaican children. Paediatrics 39: 400–411, 1967
Ashton M, Bolme P, Zerihun G. Protein binding of salicylic and salicyluric acid in serum from malnourished children: the influence of albumin, competitive binding and non-esterified fatty acids. Journal of Pharmacy and Pharmacology 41: 474–480, 1989
Bochner F, Graham GG, Polverino A, Imhoff DM, Tregenza RA, et al. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis. European Journal of Clinical Pharmacology 32: 153–158, 1987
Bravo ME, Jarpa S, Monckeberg F, Pizarro G. Cinética de niveles plasmaticos de salicilato en niños desnutridos. Revista Chilena de Pediatria 49: 45–50, 1978
Brooks SE, Goldon MH, Taylor E. Hepatic ultra-structure in children with protein-energy malnutrition. West Indian Medical Journal 41: 139–145, 1992
Chatterjee KK, Mukherjee KL. Phospholipids of the liver in children suffering from protein-calorie undernutrition. British Journal of Nutrition 22: 145–151, 1968
Editorial. Classification of infantile malnutrition. Lancet 2: 302–303, 1970
Furst DE, Tozer TN, Melmon KL. Salicylate clearance, the resultant of protein binding and metabolism. Clinical Pharmacology and Therapeutics 26: 380–389, 1979
Gibson T, Zaphiropoulos G, Grove J, Widdop B, Berry D. Kinetics of salicylate metabolism. British Journal of Clinical Pharmacology 2: 233–238, 1975
Graham GG, Champion CD, Day RO, Pauli PD. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clinical Pharmacology and Therapeutics 22: 410–420, 1977
Ho PC, Triggs EJ, Bourne DWA. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. British Journal of Clinical Pharmacology 19: 675–684, 1989
Hutt AJ, Caldwell J, Smith RL. The metabolism of [carboxyl-14C]aspirin in man. Xenobiotica 12: 601–610, 1982
Komiya I. Urine flow dependence of renal clearance and interrelation of renal reabsorption and physicochemical properties of drugs. Drug Metabolism and Disposition 14: 239–245, 1986
Levy G. Pharmacokinetics of salicylate in man. Drug Metabolism Reviews 9: 3–19, 1979
Levy G, Tsuchiya T, Amsel LP. Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clinical Pharmacology and Therapeutics 13: 258–268, 1972
Levy G, Yaffe SJ. Relationship between dose and apparent volume of distribution of salicylate in children. Paediatrics 54: 713–717, 1974
Miaskiewicz SL, Shively CA, Vesell ES. Sex differences in absorption of kinetics of sodium salicylate. Clinical Pharmacology and Therapeutics 31: 30–37, 1982
Montgomery PR, Berger LG, Mitenko PA, Sitar DS. Salicylate metabolism: effects of age and sex in adults. Clinical Pharmacology and Therapeutics 39: 571–576, 1986
Montgomery PR, Sitar DS. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets. Biopharmaceutics and Drug Disposition 7: 21–25, 1986
Øie S, Tozer TN. Effect of altered plasma protein binding on apparent volume of distribution. Journal of Pharmaceutical Sciences 68: 1203–1205, 1979
Rubin GM, Tozer TN, Øie S. Concentration-dependence of salicylate distribution. Journal of Pharmacy and Pharmacology 35: 115–117, 1983
Schachter D, Manis JG. Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. Journal of Clinical Investigation 37: 800–807, 1958
Shastri RA. Steady-state kinetics of salicylic acid in undernutrition. World Review of Nutrition and Dietetics 43: 192–197, 1984
Tandon BN, Ramanujan RA, Tandon HD, Gandhi PC. Liver injury in protein calorie malnutrition: an electron microscopic study. American Journal of Clinical Nutrition 27: 550–558, 1974
Thabrew MI, Olorunsogo OO, Olowookere JO, Bababunmi EA. Possible defect in xenobiotic activation before glycine conjugation in protein-energy malnutrition. Xenobiotica 12: 849–853, 1982
Treluyer JM, Sultan E, Alexandre JA, Roux A, Flouvat B, et al. Pharmacocinetique de l’aspirine chez l’enfant africain normonutri et malnutri. Archives Francaises de Pediatrie 48: 337–341, 1991
Varma DR, Yue TL. Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats. British Journal of Pharmacology 82: 241–248, 1984
Wilson JT, Howell RL, Holladay MW, Brills GM, Chrastil J, et al. Gentisuric acid: metabolic formation in animals and identification as a metabolite of aspirin in man. Clinical Pharmacology and Therapeutics 23: 635–643, 1978
Yue TL, Varma DR. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats. Drug Metabolism and Disposition 10: 147–152, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashton, M., Bolme, P., Zerihun, G. et al. Disposition of Salicylic Acid in Malnourished Ethiopian Children after Single Oral Dose. Clin. Pharmacokinet. 25, 483–494 (1993). https://doi.org/10.2165/00003088-199325060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199325060-00006